Pre Test

1. Isolated post-capillary pulmonary arterial hypertension is defined hemodynamically as ______________.*
2. According to the 6th World Symposium on Pulmonary Hypertension, combined pre- and post-capillary pulmonary hypertension is classified as ________________________.*
3. Chronic thromboembolic pulmonary hypertension (CTEPH) may be cured with ________________________.*
4. Which of the following is not a common side effect associated with soluble guanylate cyclase stimulators (sGC)?*
5. A 45-year-old patient with a known history of pulmonary hypertension secondary to valvular heart disease has recently moved to your area. She is a WHO functional class 4, with frequently repeated syncope, a Peak VO2 of 7 ml/min/kg, an NT-proBNP of 1470 ng/l, and a right atrial pressure of 16 mmHg. What would be the best management option for this patient?*